China Universal Asset Management »

Acrivon Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $10k 5.5k 1.81
2025-06-30 $7.5k 6.3k 1.19
2025-03-31 $13k 6.2k 2.03
2024-12-31 $40k 6.6k 6.02

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Alphabet Inc-cl A Common Stock (GOOGL)
Meta Platforms Inc-class A Common Stock (META)
Netflix Common Stock (NFLX)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Gilead Sciences Common Stock (GILD)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl C Common Stock (GOOG)
Palantir Technologies Inc-a Common Stock (PLTR)
Applovin Corp-class A Common Stock (APP)

View all positions for China Universal Asset Management

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Citadel Advisors
Wellington Management Company
UBS Group
Vanguard Group
Renaissance Technologies
Acorn Capital Advisors
BlackRock
Two Sigma Investments
Jane Street
Geode Capital Management
Millennium Management
Marshall Wace
Two Sigma Advisers

View all funds holding Acrivon Therapeutics